Diagnosis and Treatment of Polycystic Ovary Syndrome

Polycystic ovary syndrome is the common endocrinopathy among reproductive-aged females in the all over the world, affecting approximately 6% of female patients. The pathophysiology of the disease is complex and there is no single defect from which it is known to result, it is hypothesized that insulin resistance is a key factors from asymptomatic to having multiple gynecologic, dermatologic, or metabolic manifestations. Advices from the Endocrine Society mentioned using the Rotterdam criteria for diagnosis, which mandate the presence of two of the following three findings—hyperandrogenism, ovulatory dysfunction, and polycystic ovaries and plus the exclusion of other diagnoses that could result in ovulatory dysfunction.

 

  • Infertility in polycystic ovary syndrome
  • Hyperandrogenism
  • Anovulation
  • Anovulation

Related Conference of Diagnosis and Treatment of Polycystic Ovary Syndrome

May 10-11, 2021

8th Asia Pacific Gynecology and Obstetrics Congress

Singapore, Singapore
May 18-19, 2021

World congress on Women Health and Reproductive Medicine

Auckland, Newzealand
July 06-07, 2021

Annual Congress on Diabetes, Metabolism and Obesity

Sydney, Australia
July 12-13, 2021

Global summit on Maternal, Infant and Child Health

Melbourne, Australia
September 15-16, 2021

13th International Conference on Gynecology

London, UK
December 15-16, 2021

11th International Conference on Women’s Health and Cancer Cure

Prague, Czech Republic

Diagnosis and Treatment of Polycystic Ovary Syndrome Conference Speakers

Recommended Sessions

Related Journals

Are you interested in